nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—ALOX5—atherosclerosis	0.39	1	CbGaD
Montelukast—SLCO2B1—Niacin—atherosclerosis	0.111	0.251	CbGbCtD
Montelukast—SLCO2B1—Rosuvastatin—atherosclerosis	0.0945	0.214	CbGbCtD
Montelukast—SLCO2B1—Pravastatin—atherosclerosis	0.086	0.194	CbGbCtD
Montelukast—CYP2C8—Simvastatin—atherosclerosis	0.0192	0.0435	CbGbCtD
Montelukast—CYP2C8—Lovastatin—atherosclerosis	0.0188	0.0425	CbGbCtD
Montelukast—CYP2C8—Pravastatin—atherosclerosis	0.0188	0.0425	CbGbCtD
Montelukast—CYP2C9—Rosuvastatin—atherosclerosis	0.0144	0.0326	CbGbCtD
Montelukast—CYP2C9—Simvastatin—atherosclerosis	0.0134	0.0303	CbGbCtD
Montelukast—CYP2C9—Lovastatin—atherosclerosis	0.0131	0.0297	CbGbCtD
Montelukast—CYP2C9—Pravastatin—atherosclerosis	0.0131	0.0297	CbGbCtD
Montelukast—CYP3A4—Rosuvastatin—atherosclerosis	0.00839	0.019	CbGbCtD
Montelukast—CYP3A4—Ezetimibe—atherosclerosis	0.00839	0.019	CbGbCtD
Montelukast—CYP3A4—Simvastatin—atherosclerosis	0.0078	0.0176	CbGbCtD
Montelukast—CYP3A4—Lovastatin—atherosclerosis	0.00763	0.0172	CbGbCtD
Montelukast—CYP3A4—Pravastatin—atherosclerosis	0.00763	0.0172	CbGbCtD
Montelukast—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000468	0.00477	CcSEcCtD
Montelukast—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000465	0.00474	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000459	0.00467	CcSEcCtD
Montelukast—Influenza—Lovastatin—atherosclerosis	0.000458	0.00467	CcSEcCtD
Montelukast—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000456	0.00464	CcSEcCtD
Montelukast—Eosinophilia—Lovastatin—atherosclerosis	0.000454	0.00462	CcSEcCtD
Montelukast—Sinusitis—Rosuvastatin—atherosclerosis	0.000452	0.00461	CcSEcCtD
Montelukast—Influenza—Ezetimibe—atherosclerosis	0.00045	0.00458	CcSEcCtD
Montelukast—Pancreatitis—Lovastatin—atherosclerosis	0.000449	0.00457	CcSEcCtD
Montelukast—Cramp muscle—Simvastatin—atherosclerosis	0.000447	0.00455	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000447	0.00455	CcSEcCtD
Montelukast—Eosinophilia—Ezetimibe—atherosclerosis	0.000445	0.00453	CcSEcCtD
Montelukast—Pancreatitis—Ezetimibe—atherosclerosis	0.000441	0.00449	CcSEcCtD
Montelukast—Rhinitis—Rosuvastatin—atherosclerosis	0.000434	0.00442	CcSEcCtD
Montelukast—Hepatitis—Rosuvastatin—atherosclerosis	0.000433	0.00441	CcSEcCtD
Montelukast—Pharyngitis—Rosuvastatin—atherosclerosis	0.00043	0.00437	CcSEcCtD
Montelukast—Eosinophilia—Simvastatin—atherosclerosis	0.000424	0.00432	CcSEcCtD
Montelukast—Pancreatitis—Simvastatin—atherosclerosis	0.00042	0.00428	CcSEcCtD
Montelukast—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000418	0.00425	CcSEcCtD
Montelukast—Bronchitis—Simvastatin—atherosclerosis	0.000412	0.0042	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000405	0.00412	CcSEcCtD
Montelukast—Cramp muscle—Pravastatin—atherosclerosis	0.000404	0.00411	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000404	0.00411	CcSEcCtD
Montelukast—Nasopharyngitis—Pravastatin—atherosclerosis	0.000401	0.00408	CcSEcCtD
Montelukast—Infestation NOS—Ezetimibe—atherosclerosis	0.000401	0.00408	CcSEcCtD
Montelukast—Infestation—Ezetimibe—atherosclerosis	0.000401	0.00408	CcSEcCtD
Montelukast—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000401	0.00408	CcSEcCtD
Montelukast—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000398	0.00406	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000396	0.00403	CcSEcCtD
Montelukast—Influenza—Niacin—atherosclerosis	0.000394	0.00401	CcSEcCtD
Montelukast—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000393	0.004	CcSEcCtD
Montelukast—Jaundice—Ezetimibe—atherosclerosis	0.000391	0.00398	CcSEcCtD
Montelukast—Influenza—Pravastatin—atherosclerosis	0.000388	0.00395	CcSEcCtD
Montelukast—Eosinophilia—Pravastatin—atherosclerosis	0.000384	0.00391	CcSEcCtD
Montelukast—Sinusitis—Lovastatin—atherosclerosis	0.000383	0.0039	CcSEcCtD
Montelukast—Pancreatitis—Pravastatin—atherosclerosis	0.00038	0.00387	CcSEcCtD
Montelukast—Mental disorder—Rosuvastatin—atherosclerosis	0.000379	0.00386	CcSEcCtD
Montelukast—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000379	0.00386	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000379	0.00386	CcSEcCtD
Montelukast—Bronchitis—Niacin—atherosclerosis	0.000379	0.00385	CcSEcCtD
Montelukast—Sinusitis—Ezetimibe—atherosclerosis	0.000376	0.00383	CcSEcCtD
Montelukast—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000375	0.00381	CcSEcCtD
Montelukast—Jaundice—Simvastatin—atherosclerosis	0.000373	0.00379	CcSEcCtD
Montelukast—Hepatitis—Lovastatin—atherosclerosis	0.000367	0.00373	CcSEcCtD
Montelukast—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00036	0.00367	CcSEcCtD
Montelukast—Hepatitis—Ezetimibe—atherosclerosis	0.00036	0.00366	CcSEcCtD
Montelukast—Sinusitis—Simvastatin—atherosclerosis	0.000359	0.00365	CcSEcCtD
Montelukast—Pharyngitis—Ezetimibe—atherosclerosis	0.000357	0.00364	CcSEcCtD
Montelukast—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000354	0.0036	CcSEcCtD
Montelukast—Erythema multiforme—Lovastatin—atherosclerosis	0.000347	0.00353	CcSEcCtD
Montelukast—Angioedema—Rosuvastatin—atherosclerosis	0.000344	0.00351	CcSEcCtD
Montelukast—Hepatitis—Simvastatin—atherosclerosis	0.000343	0.00349	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000343	0.00349	CcSEcCtD
Montelukast—Jaundice—Niacin—atherosclerosis	0.000342	0.00348	CcSEcCtD
Montelukast—Erythema multiforme—Ezetimibe—atherosclerosis	0.00034	0.00346	CcSEcCtD
Montelukast—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000339	0.00345	CcSEcCtD
Montelukast—Jaundice—Pravastatin—atherosclerosis	0.000337	0.00343	CcSEcCtD
Montelukast—Cough—Rosuvastatin—atherosclerosis	0.000329	0.00335	CcSEcCtD
Montelukast—Immune system disorder—Ezetimibe—atherosclerosis	0.000325	0.00331	CcSEcCtD
Montelukast—Erythema multiforme—Simvastatin—atherosclerosis	0.000324	0.0033	CcSEcCtD
Montelukast—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000324	0.0033	CcSEcCtD
Montelukast—Sinusitis—Pravastatin—atherosclerosis	0.000324	0.0033	CcSEcCtD
Montelukast—Myalgia—Rosuvastatin—atherosclerosis	0.000321	0.00327	CcSEcCtD
Montelukast—Arthralgia—Rosuvastatin—atherosclerosis	0.000321	0.00327	CcSEcCtD
Montelukast—Rhinitis—Niacin—atherosclerosis	0.000316	0.00322	CcSEcCtD
Montelukast—Mental disorder—Ezetimibe—atherosclerosis	0.000315	0.00321	CcSEcCtD
Montelukast—Hepatitis—Niacin—atherosclerosis	0.000315	0.00321	CcSEcCtD
Montelukast—Hypoaesthesia—Niacin—atherosclerosis	0.000314	0.00319	CcSEcCtD
Montelukast—Rhinitis—Pravastatin—atherosclerosis	0.000311	0.00317	CcSEcCtD
Montelukast—Hepatitis—Pravastatin—atherosclerosis	0.00031	0.00316	CcSEcCtD
Montelukast—Hypoaesthesia—Pravastatin—atherosclerosis	0.000309	0.00314	CcSEcCtD
Montelukast—Pharyngitis—Pravastatin—atherosclerosis	0.000308	0.00313	CcSEcCtD
Montelukast—Muscle spasms—Lovastatin—atherosclerosis	0.000307	0.00313	CcSEcCtD
Montelukast—Infection—Rosuvastatin—atherosclerosis	0.000306	0.00311	CcSEcCtD
Montelukast—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000302	0.00307	CcSEcCtD
Montelukast—Muscle spasms—Ezetimibe—atherosclerosis	0.000301	0.00307	CcSEcCtD
Montelukast—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000301	0.00307	CcSEcCtD
Montelukast—Mental disorder—Simvastatin—atherosclerosis	0.000301	0.00306	CcSEcCtD
Montelukast—Tremor—Lovastatin—atherosclerosis	0.000299	0.00305	CcSEcCtD
Montelukast—Erythema multiforme—Pravastatin—atherosclerosis	0.000293	0.00299	CcSEcCtD
Montelukast—Angioedema—Lovastatin—atherosclerosis	0.000292	0.00297	CcSEcCtD
Montelukast—Cardiac disorder—Pravastatin—atherosclerosis	0.000288	0.00293	CcSEcCtD
Montelukast—Muscle spasms—Simvastatin—atherosclerosis	0.000287	0.00292	CcSEcCtD
Montelukast—Angioedema—Ezetimibe—atherosclerosis	0.000286	0.00291	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00028	0.00285	CcSEcCtD
Montelukast—Tremor—Simvastatin—atherosclerosis	0.00028	0.00285	CcSEcCtD
Montelukast—Insomnia—Rosuvastatin—atherosclerosis	0.000278	0.00283	CcSEcCtD
Montelukast—Palpitations—Ezetimibe—atherosclerosis	0.000277	0.00282	CcSEcCtD
Montelukast—Paraesthesia—Rosuvastatin—atherosclerosis	0.000276	0.00281	CcSEcCtD
Montelukast—Cough—Ezetimibe—atherosclerosis	0.000273	0.00278	CcSEcCtD
Montelukast—Angioedema—Simvastatin—atherosclerosis	0.000273	0.00278	CcSEcCtD
Montelukast—Myalgia—Lovastatin—atherosclerosis	0.000272	0.00277	CcSEcCtD
Montelukast—Arthralgia—Lovastatin—atherosclerosis	0.000272	0.00277	CcSEcCtD
Montelukast—Anxiety—Lovastatin—atherosclerosis	0.000271	0.00276	CcSEcCtD
Montelukast—Dyspepsia—Rosuvastatin—atherosclerosis	0.000271	0.00276	CcSEcCtD
Montelukast—Arthralgia—Ezetimibe—atherosclerosis	0.000267	0.00271	CcSEcCtD
Montelukast—Myalgia—Ezetimibe—atherosclerosis	0.000267	0.00271	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000265	0.0027	CcSEcCtD
Montelukast—Muscle spasms—Niacin—atherosclerosis	0.000264	0.00268	CcSEcCtD
Montelukast—Pain—Rosuvastatin—atherosclerosis	0.000263	0.00268	CcSEcCtD
Montelukast—Anaphylactic shock—Lovastatin—atherosclerosis	0.000261	0.00265	CcSEcCtD
Montelukast—Muscle spasms—Pravastatin—atherosclerosis	0.00026	0.00264	CcSEcCtD
Montelukast—Infection—Lovastatin—atherosclerosis	0.000259	0.00264	CcSEcCtD
Montelukast—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000256	0.0026	CcSEcCtD
Montelukast—Thrombocytopenia—Lovastatin—atherosclerosis	0.000255	0.0026	CcSEcCtD
Montelukast—Arthralgia—Simvastatin—atherosclerosis	0.000254	0.00259	CcSEcCtD
Montelukast—Myalgia—Simvastatin—atherosclerosis	0.000254	0.00259	CcSEcCtD
Montelukast—Infection—Ezetimibe—atherosclerosis	0.000254	0.00259	CcSEcCtD
Montelukast—Anxiety—Simvastatin—atherosclerosis	0.000253	0.00258	CcSEcCtD
Montelukast—Tremor—Pravastatin—atherosclerosis	0.000253	0.00258	CcSEcCtD
Montelukast—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000251	0.00256	CcSEcCtD
Montelukast—Nervous system disorder—Ezetimibe—atherosclerosis	0.000251	0.00255	CcSEcCtD
Montelukast—Angioedema—Niacin—atherosclerosis	0.000251	0.00255	CcSEcCtD
Montelukast—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00025	0.00255	CcSEcCtD
Montelukast—Skin disorder—Ezetimibe—atherosclerosis	0.000248	0.00253	CcSEcCtD
Montelukast—Angioedema—Pravastatin—atherosclerosis	0.000247	0.00251	CcSEcCtD
Montelukast—Urticaria—Rosuvastatin—atherosclerosis	0.000244	0.00249	CcSEcCtD
Montelukast—Oedema—Simvastatin—atherosclerosis	0.000244	0.00248	CcSEcCtD
Montelukast—Anaphylactic shock—Simvastatin—atherosclerosis	0.000244	0.00248	CcSEcCtD
Montelukast—Abdominal pain—Rosuvastatin—atherosclerosis	0.000243	0.00248	CcSEcCtD
Montelukast—Palpitations—Niacin—atherosclerosis	0.000242	0.00247	CcSEcCtD
Montelukast—Infection—Simvastatin—atherosclerosis	0.000242	0.00247	CcSEcCtD
Montelukast—Cough—Niacin—atherosclerosis	0.000239	0.00244	CcSEcCtD
Montelukast—Thrombocytopenia—Simvastatin—atherosclerosis	0.000239	0.00243	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000237	0.00242	CcSEcCtD
Montelukast—Insomnia—Lovastatin—atherosclerosis	0.000236	0.0024	CcSEcCtD
Montelukast—Cough—Pravastatin—atherosclerosis	0.000236	0.0024	CcSEcCtD
Montelukast—Paraesthesia—Lovastatin—atherosclerosis	0.000234	0.00238	CcSEcCtD
Montelukast—Myalgia—Niacin—atherosclerosis	0.000234	0.00238	CcSEcCtD
Montelukast—Arthralgia—Niacin—atherosclerosis	0.000234	0.00238	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000233	0.00237	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000232	0.00236	CcSEcCtD
Montelukast—Insomnia—Ezetimibe—atherosclerosis	0.000231	0.00235	CcSEcCtD
Montelukast—Arthralgia—Pravastatin—atherosclerosis	0.00023	0.00234	CcSEcCtD
Montelukast—Myalgia—Pravastatin—atherosclerosis	0.00023	0.00234	CcSEcCtD
Montelukast—Paraesthesia—Ezetimibe—atherosclerosis	0.00023	0.00234	CcSEcCtD
Montelukast—Dyspepsia—Lovastatin—atherosclerosis	0.000229	0.00234	CcSEcCtD
Montelukast—Anxiety—Pravastatin—atherosclerosis	0.000229	0.00233	CcSEcCtD
Montelukast—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000227	0.00231	CcSEcCtD
Montelukast—Dyspepsia—Ezetimibe—atherosclerosis	0.000225	0.00229	CcSEcCtD
Montelukast—Fatigue—Lovastatin—atherosclerosis	0.000225	0.00229	CcSEcCtD
Montelukast—Anaphylactic shock—Niacin—atherosclerosis	0.000224	0.00228	CcSEcCtD
Montelukast—Oedema—Niacin—atherosclerosis	0.000224	0.00228	CcSEcCtD
Montelukast—Pain—Lovastatin—atherosclerosis	0.000223	0.00227	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000222	0.00226	CcSEcCtD
Montelukast—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000221	0.00225	CcSEcCtD
Montelukast—Asthenia—Rosuvastatin—atherosclerosis	0.000221	0.00225	CcSEcCtD
Montelukast—Insomnia—Simvastatin—atherosclerosis	0.000221	0.00224	CcSEcCtD
Montelukast—Anaphylactic shock—Pravastatin—atherosclerosis	0.00022	0.00224	CcSEcCtD
Montelukast—Oedema—Pravastatin—atherosclerosis	0.00022	0.00224	CcSEcCtD
Montelukast—Fatigue—Ezetimibe—atherosclerosis	0.00022	0.00224	CcSEcCtD
Montelukast—Infection—Pravastatin—atherosclerosis	0.000219	0.00223	CcSEcCtD
Montelukast—Paraesthesia—Simvastatin—atherosclerosis	0.000219	0.00223	CcSEcCtD
Montelukast—Pain—Ezetimibe—atherosclerosis	0.000219	0.00223	CcSEcCtD
Montelukast—Pruritus—Rosuvastatin—atherosclerosis	0.000218	0.00222	CcSEcCtD
Montelukast—Skin disorder—Niacin—atherosclerosis	0.000217	0.00221	CcSEcCtD
Montelukast—Thrombocytopenia—Pravastatin—atherosclerosis	0.000216	0.0022	CcSEcCtD
Montelukast—Dyspepsia—Simvastatin—atherosclerosis	0.000215	0.00218	CcSEcCtD
Montelukast—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000213	0.00217	CcSEcCtD
Montelukast—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00021	0.00214	CcSEcCtD
Montelukast—Diarrhoea—Rosuvastatin—atherosclerosis	0.00021	0.00214	CcSEcCtD
Montelukast—Fatigue—Simvastatin—atherosclerosis	0.00021	0.00214	CcSEcCtD
Montelukast—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000209	0.00213	CcSEcCtD
Montelukast—Pain—Simvastatin—atherosclerosis	0.000208	0.00212	CcSEcCtD
Montelukast—Urticaria—Lovastatin—atherosclerosis	0.000207	0.00211	CcSEcCtD
Montelukast—Abdominal pain—Lovastatin—atherosclerosis	0.000206	0.0021	CcSEcCtD
Montelukast—Body temperature increased—Lovastatin—atherosclerosis	0.000206	0.0021	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000204	0.00208	CcSEcCtD
Montelukast—Dizziness—Rosuvastatin—atherosclerosis	0.000203	0.00207	CcSEcCtD
Montelukast—Urticaria—Ezetimibe—atherosclerosis	0.000203	0.00207	CcSEcCtD
Montelukast—Insomnia—Niacin—atherosclerosis	0.000202	0.00206	CcSEcCtD
Montelukast—Body temperature increased—Ezetimibe—atherosclerosis	0.000202	0.00206	CcSEcCtD
Montelukast—Abdominal pain—Ezetimibe—atherosclerosis	0.000202	0.00206	CcSEcCtD
Montelukast—Paraesthesia—Niacin—atherosclerosis	0.000201	0.00205	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000201	0.00204	CcSEcCtD
Montelukast—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000199	0.00203	CcSEcCtD
Montelukast—Insomnia—Pravastatin—atherosclerosis	0.000199	0.00203	CcSEcCtD
Montelukast—Somnolence—Niacin—atherosclerosis	0.000199	0.00203	CcSEcCtD
Montelukast—Paraesthesia—Pravastatin—atherosclerosis	0.000198	0.00201	CcSEcCtD
Montelukast—Dyspepsia—Niacin—atherosclerosis	0.000197	0.00201	CcSEcCtD
Montelukast—Dyspepsia—Pravastatin—atherosclerosis	0.000194	0.00198	CcSEcCtD
Montelukast—Rash—Rosuvastatin—atherosclerosis	0.000194	0.00197	CcSEcCtD
Montelukast—Dermatitis—Rosuvastatin—atherosclerosis	0.000194	0.00197	CcSEcCtD
Montelukast—Urticaria—Simvastatin—atherosclerosis	0.000194	0.00197	CcSEcCtD
Montelukast—Gastrointestinal disorder—Niacin—atherosclerosis	0.000193	0.00197	CcSEcCtD
Montelukast—Abdominal pain—Simvastatin—atherosclerosis	0.000193	0.00196	CcSEcCtD
Montelukast—Body temperature increased—Simvastatin—atherosclerosis	0.000193	0.00196	CcSEcCtD
Montelukast—Headache—Rosuvastatin—atherosclerosis	0.000193	0.00196	CcSEcCtD
Montelukast—Hypersensitivity—Lovastatin—atherosclerosis	0.000192	0.00195	CcSEcCtD
Montelukast—Pain—Niacin—atherosclerosis	0.000191	0.00195	CcSEcCtD
Montelukast—Fatigue—Pravastatin—atherosclerosis	0.00019	0.00193	CcSEcCtD
Montelukast—Pain—Pravastatin—atherosclerosis	0.000188	0.00192	CcSEcCtD
Montelukast—Hypersensitivity—Ezetimibe—atherosclerosis	0.000188	0.00192	CcSEcCtD
Montelukast—Asthenia—Lovastatin—atherosclerosis	0.000187	0.0019	CcSEcCtD
Montelukast—Pruritus—Lovastatin—atherosclerosis	0.000184	0.00188	CcSEcCtD
Montelukast—Asthenia—Ezetimibe—atherosclerosis	0.000183	0.00187	CcSEcCtD
Montelukast—Gastrointestinal pain—Niacin—atherosclerosis	0.000183	0.00186	CcSEcCtD
Montelukast—Nausea—Rosuvastatin—atherosclerosis	0.000183	0.00186	CcSEcCtD
Montelukast—Pruritus—Ezetimibe—atherosclerosis	0.000181	0.00184	CcSEcCtD
Montelukast—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00018	0.00183	CcSEcCtD
Montelukast—Hypersensitivity—Simvastatin—atherosclerosis	0.00018	0.00183	CcSEcCtD
Montelukast—Diarrhoea—Lovastatin—atherosclerosis	0.000178	0.00182	CcSEcCtD
Montelukast—Urticaria—Niacin—atherosclerosis	0.000178	0.00181	CcSEcCtD
Montelukast—Abdominal pain—Niacin—atherosclerosis	0.000177	0.0018	CcSEcCtD
Montelukast—Body temperature increased—Niacin—atherosclerosis	0.000177	0.0018	CcSEcCtD
Montelukast—Urticaria—Pravastatin—atherosclerosis	0.000175	0.00178	CcSEcCtD
Montelukast—Asthenia—Simvastatin—atherosclerosis	0.000175	0.00178	CcSEcCtD
Montelukast—Diarrhoea—Ezetimibe—atherosclerosis	0.000175	0.00178	CcSEcCtD
Montelukast—Body temperature increased—Pravastatin—atherosclerosis	0.000174	0.00177	CcSEcCtD
Montelukast—Abdominal pain—Pravastatin—atherosclerosis	0.000174	0.00177	CcSEcCtD
Montelukast—Pruritus—Simvastatin—atherosclerosis	0.000172	0.00176	CcSEcCtD
Montelukast—Dizziness—Lovastatin—atherosclerosis	0.000172	0.00175	CcSEcCtD
Montelukast—Dizziness—Ezetimibe—atherosclerosis	0.000169	0.00172	CcSEcCtD
Montelukast—Diarrhoea—Simvastatin—atherosclerosis	0.000167	0.0017	CcSEcCtD
Montelukast—Vomiting—Lovastatin—atherosclerosis	0.000166	0.00169	CcSEcCtD
Montelukast—Hypersensitivity—Niacin—atherosclerosis	0.000165	0.00168	CcSEcCtD
Montelukast—Rash—Lovastatin—atherosclerosis	0.000164	0.00167	CcSEcCtD
Montelukast—Dermatitis—Lovastatin—atherosclerosis	0.000164	0.00167	CcSEcCtD
Montelukast—Headache—Lovastatin—atherosclerosis	0.000163	0.00166	CcSEcCtD
Montelukast—Vomiting—Ezetimibe—atherosclerosis	0.000163	0.00165	CcSEcCtD
Montelukast—Hypersensitivity—Pravastatin—atherosclerosis	0.000162	0.00165	CcSEcCtD
Montelukast—Dizziness—Simvastatin—atherosclerosis	0.000161	0.00164	CcSEcCtD
Montelukast—Rash—Ezetimibe—atherosclerosis	0.000161	0.00164	CcSEcCtD
Montelukast—Dermatitis—Ezetimibe—atherosclerosis	0.000161	0.00164	CcSEcCtD
Montelukast—Asthenia—Niacin—atherosclerosis	0.000161	0.00164	CcSEcCtD
Montelukast—Headache—Ezetimibe—atherosclerosis	0.00016	0.00163	CcSEcCtD
Montelukast—Pruritus—Niacin—atherosclerosis	0.000158	0.00161	CcSEcCtD
Montelukast—Asthenia—Pravastatin—atherosclerosis	0.000158	0.00161	CcSEcCtD
Montelukast—Pruritus—Pravastatin—atherosclerosis	0.000156	0.00159	CcSEcCtD
Montelukast—Vomiting—Simvastatin—atherosclerosis	0.000155	0.00158	CcSEcCtD
Montelukast—Nausea—Lovastatin—atherosclerosis	0.000155	0.00158	CcSEcCtD
Montelukast—Rash—Simvastatin—atherosclerosis	0.000154	0.00156	CcSEcCtD
Montelukast—Dermatitis—Simvastatin—atherosclerosis	0.000154	0.00156	CcSEcCtD
Montelukast—Diarrhoea—Niacin—atherosclerosis	0.000153	0.00156	CcSEcCtD
Montelukast—Headache—Simvastatin—atherosclerosis	0.000153	0.00155	CcSEcCtD
Montelukast—Nausea—Ezetimibe—atherosclerosis	0.000152	0.00155	CcSEcCtD
Montelukast—Diarrhoea—Pravastatin—atherosclerosis	0.000151	0.00154	CcSEcCtD
Montelukast—Dizziness—Niacin—atherosclerosis	0.000148	0.00151	CcSEcCtD
Montelukast—Dizziness—Pravastatin—atherosclerosis	0.000146	0.00148	CcSEcCtD
Montelukast—Nausea—Simvastatin—atherosclerosis	0.000145	0.00147	CcSEcCtD
Montelukast—Vomiting—Niacin—atherosclerosis	0.000142	0.00145	CcSEcCtD
Montelukast—Rash—Niacin—atherosclerosis	0.000141	0.00144	CcSEcCtD
Montelukast—Dermatitis—Niacin—atherosclerosis	0.000141	0.00144	CcSEcCtD
Montelukast—Headache—Niacin—atherosclerosis	0.00014	0.00143	CcSEcCtD
Montelukast—Vomiting—Pravastatin—atherosclerosis	0.00014	0.00143	CcSEcCtD
Montelukast—Rash—Pravastatin—atherosclerosis	0.000139	0.00141	CcSEcCtD
Montelukast—Dermatitis—Pravastatin—atherosclerosis	0.000139	0.00141	CcSEcCtD
Montelukast—Headache—Pravastatin—atherosclerosis	0.000138	0.00141	CcSEcCtD
Montelukast—Nausea—Niacin—atherosclerosis	0.000133	0.00135	CcSEcCtD
Montelukast—Nausea—Pravastatin—atherosclerosis	0.000131	0.00133	CcSEcCtD
Montelukast—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.37e-05	0.000198	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.37e-05	0.000198	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—MAPK3—atherosclerosis	1.37e-05	0.000197	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PLA2G1B—atherosclerosis	1.37e-05	0.000197	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.36e-05	0.000195	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—INS—atherosclerosis	1.35e-05	0.000195	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCG1—atherosclerosis	1.33e-05	0.000192	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCL2—atherosclerosis	1.33e-05	0.000192	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CG—atherosclerosis	1.32e-05	0.000191	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALOX5—atherosclerosis	1.32e-05	0.00019	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF1—atherosclerosis	1.31e-05	0.000188	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.29e-05	0.000186	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.28e-05	0.000185	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARG—atherosclerosis	1.28e-05	0.000184	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—FABP4—atherosclerosis	1.25e-05	0.000181	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LCAT—atherosclerosis	1.25e-05	0.000181	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—INS—atherosclerosis	1.25e-05	0.000181	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NAMPT—atherosclerosis	1.25e-05	0.00018	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.24e-05	0.000179	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—LIPC—atherosclerosis	1.24e-05	0.000179	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SERPINE1—atherosclerosis	1.24e-05	0.000179	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOC3—atherosclerosis	1.24e-05	0.000178	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOA4—atherosclerosis	1.23e-05	0.000177	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—LDLR—atherosclerosis	1.23e-05	0.000177	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP7A1—atherosclerosis	1.21e-05	0.000174	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CETP—atherosclerosis	1.2e-05	0.000173	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOS3—atherosclerosis	1.19e-05	0.000171	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NAMPT—atherosclerosis	1.18e-05	0.000171	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—LIPC—atherosclerosis	1.18e-05	0.000169	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOC3—atherosclerosis	1.17e-05	0.000168	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—LDLR—atherosclerosis	1.16e-05	0.000167	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.15e-05	0.000166	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ALB—atherosclerosis	1.15e-05	0.000166	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SCARB1—atherosclerosis	1.15e-05	0.000166	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.14e-05	0.000165	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CETP—atherosclerosis	1.13e-05	0.000164	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.12e-05	0.000161	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP27A1—atherosclerosis	1.12e-05	0.000161	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.11e-05	0.00016	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.1e-05	0.000159	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—NOS3—atherosclerosis	1.1e-05	0.000158	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SCARB1—atherosclerosis	1.09e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.09e-05	0.000157	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HMGCR—atherosclerosis	1.09e-05	0.000156	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.07e-05	0.000155	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALOX15—atherosclerosis	1.06e-05	0.000153	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	1.06e-05	0.000153	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	1.06e-05	0.000153	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOA2—atherosclerosis	1.06e-05	0.000153	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CXCL8—atherosclerosis	1.05e-05	0.000152	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.05e-05	0.000151	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.05e-05	0.000151	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLTP—atherosclerosis	1.05e-05	0.000151	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HMGCR—atherosclerosis	1.03e-05	0.000148	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—FABP4—atherosclerosis	1.02e-05	0.000147	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LCAT—atherosclerosis	1.02e-05	0.000147	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—atherosclerosis	1.02e-05	0.000146	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LPA—atherosclerosis	1.01e-05	0.000146	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—atherosclerosis	1.01e-05	0.000145	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOA4—atherosclerosis	1e-05	0.000144	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—atherosclerosis	1e-05	0.000144	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP7A1—atherosclerosis	9.85e-06	0.000142	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—BGN—atherosclerosis	9.79e-06	0.000141	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.79e-06	0.000141	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.72e-06	0.00014	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOA5—atherosclerosis	9.7e-06	0.00014	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCA1—atherosclerosis	9.67e-06	0.000139	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP9—atherosclerosis	9.51e-06	0.000137	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.42e-06	0.000136	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NFKB1—atherosclerosis	9.41e-06	0.000136	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	9.38e-06	0.000135	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	9.33e-06	0.000134	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK8—atherosclerosis	9.25e-06	0.000133	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—atherosclerosis	9.23e-06	0.000133	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.23e-06	0.000133	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCA1—atherosclerosis	9.15e-06	0.000132	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.14e-06	0.000132	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.12e-06	0.000131	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP27A1—atherosclerosis	9.1e-06	0.000131	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCG8—atherosclerosis	9.06e-06	0.000131	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LTA4H—atherosclerosis	9.06e-06	0.000131	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALOX5—atherosclerosis	9.01e-06	0.00013	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	8.96e-06	0.000129	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	8.74e-06	0.000126	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALOX15—atherosclerosis	8.63e-06	0.000124	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	8.63e-06	0.000124	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOA2—atherosclerosis	8.63e-06	0.000124	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	8.63e-06	0.000124	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—atherosclerosis	8.54e-06	0.000123	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCG5—atherosclerosis	8.52e-06	0.000123	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.51e-06	0.000123	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—atherosclerosis	8.46e-06	0.000122	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.33e-06	0.00012	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HMOX1—atherosclerosis	8.3e-06	0.00012	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LPA—atherosclerosis	8.23e-06	0.000119	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NAMPT—atherosclerosis	8.08e-06	0.000117	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK3—atherosclerosis	8.08e-06	0.000116	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.04e-06	0.000116	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LIPC—atherosclerosis	8.03e-06	0.000116	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOC3—atherosclerosis	7.98e-06	0.000115	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—BGN—atherosclerosis	7.97e-06	0.000115	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOB—atherosclerosis	7.95e-06	0.000115	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LDLR—atherosclerosis	7.94e-06	0.000114	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.91e-06	0.000114	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOA5—atherosclerosis	7.89e-06	0.000114	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HMOX1—atherosclerosis	7.85e-06	0.000113	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—atherosclerosis	7.84e-06	0.000113	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CETP—atherosclerosis	7.75e-06	0.000112	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTM1—atherosclerosis	7.73e-06	0.000111	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.66e-06	0.00011	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	7.6e-06	0.000109	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—LPL—atherosclerosis	7.59e-06	0.000109	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOB—atherosclerosis	7.52e-06	0.000108	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.51e-06	0.000108	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.44e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.42e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SCARB1—atherosclerosis	7.42e-06	0.000107	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPX1—atherosclerosis	7.4e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALOX5—atherosclerosis	7.34e-06	0.000106	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTM1—atherosclerosis	7.31e-06	0.000105	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.23e-06	0.000104	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CD36—atherosclerosis	7.21e-06	0.000104	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—LPL—atherosclerosis	7.18e-06	0.000103	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCG1—atherosclerosis	7.16e-06	0.000103	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMGCR—atherosclerosis	7.01e-06	0.000101	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPX1—atherosclerosis	7e-06	0.000101	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MTHFR—atherosclerosis	6.83e-06	9.85e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CD36—atherosclerosis	6.82e-06	9.83e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.78e-06	9.77e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—FABP4—atherosclerosis	6.73e-06	9.7e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LCAT—atherosclerosis	6.73e-06	9.7e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARA—atherosclerosis	6.7e-06	9.66e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOA4—atherosclerosis	6.61e-06	9.53e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NAMPT—atherosclerosis	6.58e-06	9.48e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.54e-06	9.43e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LIPC—atherosclerosis	6.54e-06	9.42e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOC3—atherosclerosis	6.5e-06	9.36e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP7A1—atherosclerosis	6.49e-06	9.36e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AGT—atherosclerosis	6.49e-06	9.36e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MTHFR—atherosclerosis	6.46e-06	9.31e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LDLR—atherosclerosis	6.46e-06	9.31e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOE—atherosclerosis	6.36e-06	9.17e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARA—atherosclerosis	6.34e-06	9.14e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.32e-06	9.11e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CETP—atherosclerosis	6.31e-06	9.09e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CAV1—atherosclerosis	6.3e-06	9.08e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOA1—atherosclerosis	6.29e-06	9.06e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCA1—atherosclerosis	6.25e-06	9e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AGT—atherosclerosis	6.14e-06	8.85e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SCARB1—atherosclerosis	6.04e-06	8.71e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOE—atherosclerosis	6.02e-06	8.67e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP27A1—atherosclerosis	6e-06	8.65e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CAV1—atherosclerosis	5.96e-06	8.59e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOA1—atherosclerosis	5.95e-06	8.57e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—atherosclerosis	5.91e-06	8.52e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.88e-06	8.48e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CG—atherosclerosis	5.74e-06	8.27e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMGCR—atherosclerosis	5.7e-06	8.22e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOA2—atherosclerosis	5.69e-06	8.2e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.69e-06	8.2e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.69e-06	8.2e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.69e-06	8.2e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.62e-06	8.1e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—atherosclerosis	5.54e-06	7.99e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—atherosclerosis	5.45e-06	7.86e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—INS—atherosclerosis	5.43e-06	7.83e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CG—atherosclerosis	5.43e-06	7.82e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LPA—atherosclerosis	5.43e-06	7.82e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMOX1—atherosclerosis	5.36e-06	7.72e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—BGN—atherosclerosis	5.26e-06	7.58e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—atherosclerosis	5.24e-06	7.55e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOA5—atherosclerosis	5.2e-06	7.5e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.15e-06	7.42e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—INS—atherosclerosis	5.14e-06	7.41e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOB—atherosclerosis	5.13e-06	7.4e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.08e-06	7.33e-05	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—atherosclerosis	5.05e-06	7.28e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.01e-06	7.22e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.99e-06	7.2e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—atherosclerosis	4.98e-06	7.18e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LPL—atherosclerosis	4.9e-06	7.07e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.84e-06	6.97e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPX1—atherosclerosis	4.78e-06	6.89e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NOS3—atherosclerosis	4.77e-06	6.87e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—atherosclerosis	4.71e-06	6.79e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CD36—atherosclerosis	4.66e-06	6.71e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NOS3—atherosclerosis	4.51e-06	6.5e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.41e-06	6.36e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMOX1—atherosclerosis	4.36e-06	6.29e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—atherosclerosis	4.36e-06	6.28e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.34e-06	6.25e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARA—atherosclerosis	4.33e-06	6.24e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LIPC—atherosclerosis	4.31e-06	6.21e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOC3—atherosclerosis	4.29e-06	6.18e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LDLR—atherosclerosis	4.26e-06	6.14e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AGT—atherosclerosis	4.19e-06	6.04e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOB—atherosclerosis	4.18e-06	6.02e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CETP—atherosclerosis	4.16e-06	6e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—atherosclerosis	4.12e-06	5.94e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOE—atherosclerosis	4.11e-06	5.92e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CAV1—atherosclerosis	4.07e-06	5.87e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.06e-06	5.86e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOA1—atherosclerosis	4.06e-06	5.85e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LPL—atherosclerosis	3.99e-06	5.75e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.98e-06	5.74e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPX1—atherosclerosis	3.89e-06	5.61e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CD36—atherosclerosis	3.79e-06	5.46e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.76e-06	5.42e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.71e-06	5.34e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.59e-06	5.18e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—atherosclerosis	3.58e-06	5.16e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARA—atherosclerosis	3.52e-06	5.08e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—INS—atherosclerosis	3.51e-06	5.06e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AGT—atherosclerosis	3.41e-06	4.92e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.35e-06	4.83e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOE—atherosclerosis	3.34e-06	4.82e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CAV1—atherosclerosis	3.31e-06	4.78e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOA1—atherosclerosis	3.31e-06	4.76e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—atherosclerosis	3.22e-06	4.64e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NOS3—atherosclerosis	3.08e-06	4.44e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.02e-06	4.35e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—atherosclerosis	2.91e-06	4.2e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.88e-06	4.15e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—INS—atherosclerosis	2.86e-06	4.12e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.82e-06	4.06e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOB—atherosclerosis	2.76e-06	3.97e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.68e-06	3.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LPL—atherosclerosis	2.63e-06	3.79e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—atherosclerosis	2.62e-06	3.77e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPX1—atherosclerosis	2.57e-06	3.7e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NOS3—atherosclerosis	2.51e-06	3.61e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CD36—atherosclerosis	2.5e-06	3.6e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.37e-06	3.41e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARA—atherosclerosis	2.32e-06	3.35e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.29e-06	3.3e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AGT—atherosclerosis	2.25e-06	3.24e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOE—atherosclerosis	2.21e-06	3.18e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—atherosclerosis	2.19e-06	3.16e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CAV1—atherosclerosis	2.19e-06	3.15e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOA1—atherosclerosis	2.18e-06	3.14e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—atherosclerosis	2.07e-06	2.99e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.99e-06	2.87e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—atherosclerosis	1.92e-06	2.77e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—INS—atherosclerosis	1.88e-06	2.72e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—atherosclerosis	1.73e-06	2.49e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NOS3—atherosclerosis	1.65e-06	2.38e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.51e-06	2.18e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—atherosclerosis	1.42e-06	2.04e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—atherosclerosis	1.15e-06	1.66e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—atherosclerosis	7.6e-07	1.09e-05	CbGpPWpGaD
